Medically reviewed by Lindsay Cook, PharmD Narcolepsy is a chronic brain disorder that disrupts sleep-wake cycles. People ...

Hallucinations. Sleep paralysis. Excessive daytime sleepiness. Jenny Lee-Gilmore was diagnosed with Type 1 narcolepsy at 21 — ...

I feel myself weightless, but like I literally cannot move. I thought narcolepsy was what we saw on TV. I had no basis for understanding it, and I never done my own research to actually figure out ...

Model Lee Hyun-yi confessed that she was diagnosed with narcolepsy, a rare and intractable disease.According to the Health ...

People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...

Samelisant (SUVNG-3031) is under development for the treatment of narcolepsy with and without cataplexy and cognitive disorders. The drug candidate is administered orally in the form of tablet. The ...

Narcolepsy is a sleep disorder that affects the brain ability to regulate sleep-wake cycles and it can present unique challenges for adolescents Teenagers with narcolepsy experience symptoms like exce ...

017). Topline results were announced from a phase 3 trial evaluating AXS-12 (reboxetine) in patients with narcolepsy. AXS-12 is an investigational highly selective potent norepinephrine reuptake ...

Jazz's neuroscience franchise faces declining Xyrem sales but sees growth in Xywav and Epidiolex. Oncology growth is driven ...

Axsome's AXS-12 met its primary endpoint in a Phase 3 study, significantly reducing cataplexy attacks in narcolepsy patients, positioning it for an NDA submission. The narcolepsy market is ...

NEWARK, Del, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The Narcolepsy Treatment Market 2024 to 2034 is expected to experience substantial growth, with the market size projected to expand from USD 5,301.6 ...